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Physical activity is a predictor of all-cause mortality
in patients with intermittent claudication
Andrew W. Gardner, PhD,a,b,c Polly S. Montgomery, MS,a,b,c and Donald E. Parker, PhD,d Oklahoma
City, Okla; and Baltimore, Md
Objective: We examined whether all-cause mortality was predicted by physical activity level in peripheral arterial disease
(PAD) patients limited by intermittent claudication.
Methods: This retrospective, natural history follow-up study determined survival status of each patient. Patients with
stable symptoms of intermittent claudication were evaluated in the Geriatrics, Research, Education, and Clinical Center
at the Maryland Veterans Affairs Health Care System (MVAHCS) at Baltimore between 1994 and 2002, and were
classified into a physically sedentary group (n  299) or a physically active group (n 135), and followed in 2004 using
the Social Security Death Index.
Results:Median follow-upwas 5.33 years (range 0.25 to 8.33 years) for the physically active group, and 5.0 years (range
 0.17 to 8.5 years) for the sedentary group. At follow-up, 108 patients (24.9%) had died, consisting of 86 (28.8%) in
the sedentary group and 22 (16.3%) in the active group. Unadjusted risk of mortality was lower (P  .005) in the
physically active group (hazard ratio [HR] 0.510, 95%CI 0.319 to 0.816). Inmultivariate Cox proportional hazards
analysis, age (HR 1.045, 95%CI 1.019 to 1.072, P< 0.001), bodymass index (BMI) (HR 0.943, 95%CI 0.902
to 0.986, P  0.009), ankle-brachial index (ABI) (HR  0.202, 95% CI  0.064 to 0.632, p  0.006), and physical
activity status (HR  0.595, 95% CI  0.370 to 0.955, P  .031) were predictors of mortality.
Conclusion: Patients limited by intermittent claudication who engage in any amount of weekly physical activity beyond
light intensity at baseline have a lower mortality rate than their sedentary counterparts who perform either no physical
activity or only light-intensity activities. The protective effect of physical activity persists even after adjusting for other
predictors of mortality, which include age, ABI, and BMI. (J Vasc Surg 2008;47:117-22.)Peripheral arterial disease (PAD) is a strong prognostic
indicator of poor long-term survival,1-14 as the relative risk
for all-cause mortality associated with PAD ranges between
1.4 and 3.8.1,4,5,7,8,10,11,14 The prognosis worsens with
more severe PAD, as the relative risk for mortality progres-
sively increases with a decrease in the ankle-brachial index
(ABI).3,6,7,10,11 Intermittent claudication afflicts 5% of the
US population older than 55 years of age15 and occurs
during ambulation when the peripheral circulation is inad-
equate to meet the metabolic requirement of the active leg
musculature. Consequently, patients with intermittent
claudication have ambulatory dysfunction, thereby limiting
daily physical activities16 and negatively affecting health-
related quality of life.17 Because ambulation is one of the
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doi:10.1016/j.jvs.2007.09.033primary physical activities performed by the elderly,18 it is
not surprising that PAD subjects adopt a sedentary life-
style.19
The poor prognosis of patients with PAD is further
compounded by sedentary living.20-22 The mortality risk of
sedentary PAD patients is higher than their more physically
active counterparts.23 Although physical activity is associ-
ated with survival in PAD patients,23 it is uncertain whether
this relationship exists in symptomatic patients who are
functionally limited by intermittent claudication. It is un-
clear whether PAD patients with intermittent claudication
are capable of performing an adequate volume of physical
activity to elicit health benefits that may lower their mor-
tality risk.
The aim of this investigation was to determine whether
all-cause mortality was predicted by physical activity level in
PAD patients limited by intermittent claudication. It was
hypothesized that (1) a higher level of physical activity
would be predictive of a lower rate of all-cause mortality,
and (2) physical activity level would remain predictive of
all-cause mortality after adjusting for ABI and comorbid
conditions in PAD patients limited by intermittent claudi-
cation.
METHODS
Patients
Screening. A total of 434 PAD patients with stable
symptoms of intermittent claudication were evaluated in
the Geriatrics, Research, Education, and Clinical Center at
the Maryland Veterans Affairs Health Care System
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of these patients were enrolled in subsequent exercise pro-
grams offered at the MVAHCS. They participated in this
study to receive information regarding their physical func-
tion, physical activity, peripheral circulation, comorbid
conditions, and cardiovascular risk factors. The patients
were recruited from the Vascular Clinic at the site of the
Baltimore MVAHCS and from local newspaper and radio
advertisements. All patients were classified as having Fon-
taine stage II PAD24 defined by the following inclusion
criteria: (1) a history of intermittent claudication, (2) an
ABI at rest 0.90,15 and (3) the occurrence of intermittent
claudication during a 6-minute walk test. Patients were
excluded from this study for the following conditions: (1)
absence of PAD, (2) inability to obtain an ABImeasure due
to noncompressible vessels, (3) asymptomatic PAD (Fon-
taine stage I), (4) rest pain PAD (Fontaine stage III), (5)
use of medications indicated for the treatment of intermit-
tent claudication (cilostazol and pentoxifylline) within
three months prior to investigation, (6) exercise tolerance
limited by factors other than claudication (eg, severe coro-
nary artery disease, dyspnea, poorly controlled blood pres-
sure), and (7) active cancer, renal disease (serum creatinine
value greater than 1.2 mg/dl), or liver disease. All patients
lived independently at home. The Institutional Review
Boards at the University of Maryland and the MVAHCS at
Baltimore approved the procedures used in this study.
Written informed consent was obtained from each patient
prior to investigation.
Physical activity status. The Johnson Space Center
(JSC) physical activity scale was used to assess the activity
level of the participants over the preceding month.25 This
8-point Likert scale consists of the following score choices:
0  avoid physical activities whenever possible, 1  light
physical activities done occasionally, 2moderate physical
activities done regularly for less than 1 hour per week, 3 
moderate physical activities done regularly for more than 1
hour per week, 4  heavy physical activities done regularly
for less than 30 minutes per week, 5  heavy physical
activities done regularly between 30 and 60 minutes per
week, 6  heavy physical activities done regularly between
1 and 3 hours per week, and 7  heavy physical activities
done regularly for more than 3 hours per week. The pa-
tients were asked to select the appropriate score (0 to 7)
which best described their general level of physical activity
for the previous month. The distribution of scores from this
scale was as follows: “0” n 57, “1” n 241, “2” n 57,
“3” n  73, “4” n  2, “5” n  1, “6” n  0, and “7”
n  3.
Patients who selected a score of either 0 or 1 were
classified as physically sedentary (n  299) because these
activity values represent either no physical activity per-
formed, or an insufficient and inconsistent amount of phys-
ical activity that was far below the minimum recommenda-
tions.26 Those patients who selected a score of 2 or higher
were classified as physically active (n  135) because these
activity levels either approach or exceed the recommenda-
tions. The JSC physical activity scale has a strong, indepen-dent relationship with maximal oxygen uptake in men and
women between the ages of 20 and 79 years.25,27
Baseline measurements
Medical history and physical examination. Demo-
graphic information, cardiovascular risk factors, comorbid
conditions, claudication history, a complete metabolic
panel blood draw, and a list of current medications were
obtained during a medical history interview and a physical
examination.
ABI. After 10 minutes of supine rest, the ankle and
brachial systolic blood pressures were obtained as previ-
ously described.28,29 The ABI was calculated as ankle sys-
tolic pressure/brachial systolic pressure.
Six-minute walk test. Patients performed a 6-minute
walk test in a hallway supervised by trained exercise techni-
cians as previously described.30 The pain-free and total
distance walked during the test were recorded.
Walking Impairment Questionnaire (WIQ). Self-
reported ambulatory ability was assessed using a validated
questionnaire for PAD patients that assesses ability to walk
at various speeds and distances, and to climb stairs.31
Anthropometry. Height was recorded from a stadi-
ometer (SECA Corporation, Hamburg, Germany) and
body weight was recorded from a balance beam scale
(Health-O-Meter Inc, Bridgeview, Ill) without shoes.
From these measurements, body mass index (BMI) was
calculated as follows: weight (kg)/height (m)2. The waist/
hip ratio was obtained from the minimal waist and maximal
hip circumferences with a steel measuring tape according to
recent recommendations.32
Survival status at follow-up
This retrospective, natural history follow-up study de-
termined survival status of each patient in 2004 using the
Social Security Death Index from the Ancestry.com web-
site. One investigator (PSM), who was blinded to the
group assignment, entered each patient’s first name, last
name, social security number, and date of birth to deter-
mine whether the patient was deceased, and if so, the date
of death. The search results listed at least one potential
match for each patient, and the entered information in
addition to the last known residence was used to confirm a
match. Survival status information was obtained on all of
the patients in the study.
Statistical analyses.
Independent t tests and 2 tests were used to examine
baseline differences in the measurements between the sed-
entary and physically active patients. The effect of the
baseline physical activity status on survival without adjust-
ment for other variables was examined using Kaplan-Meier
survival curves with log rank test. A hierarchical forward
selection with switching method was used to obtain a
multivariate Cox proportional hazards prediction model
for mortality. Included as possible selection variables were
the continuous variables age, ABI, BMI, and categorical
variables that included baseline physical activity status, each
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more, a backward stepwise procedure was used to reduce
the full model with all variables to a model with only
variables that remained significant after adjustment for
others in the model. All analyses were performed using the
NCSS statistical package. Statistical significance was set at P
 .05. Measurements are presented as means  standard
deviations.
RESULTS
The physically active patients were younger (P .015)
and had a higher ABI (P  .001) than the sedentary
patients (Table I). The physically active group had higher
levels of activity (P  .001), as well as higher ambulatory
function determined from the 6-minute walk and WIQ
measurements (P  .001) (Table II).
The median follow-up period was 5.33 years (range 
0.25 to 8.33 years) for the physically active group, and 5.0
years (range  0.17 to 8.5 years) for the sedentary group.
Table I. Baseline characteristics of sedentary and active
patients with intermittent claudication
Variables
Sedentary
group
(n  299)
Active
group
(n  135)
P
value
Age (years) 69 (8) 66 (8) .015
Weight (kg) 80.5 (15.7) 81.2 (14.0) .677
Body mass index (kg)/(meter)2 27.7 (4.8) 27.9 (4.4) .760
Waist/hip ratio 0.94 (0.08) 0.94 (0.07) .655
Ankle-brachial index 0.59 (0.17) 0.65 (0.16) .001
Sex (% men) 87 86 .844
Race (% Caucasian) 58 57 .329
Myocardial infarction (%) 30 26 .420
Current smoking (%) 41 42 .894
Diabetes (%) 33 31 .829
Hypertension (%) 64 59 .557
Hyperlipidemia (%) 49 56 .253
COPD (%) 15 8 .061
IC, Intermittent claudication; COPD, chronic obstructive pulmonary dis-
ease.
Values are means (SD) and percentages.
Table II. Baseline physical activity level and ambulatory
function of sedentary and active patients with intermittent
claudication
Variables
Sedentary group
(n  299)
Active group
(n  135) P value
Physical activity scale
(activity score) 0.8 (0.4) 2.7 (0.9) .001
6-minute walk distance
(meters) 341 (86) 400 (92) .001
WIQ distance score (%) 26 (28) 40 (32) .001
WIQ speed score (%) 27 (24) 43 (27) .001
WIQ stair climbing
score (%) 32 (30) 54 (34) .001
WIQ, Walking impairment questionnaire.
Values are means (SD).At follow-up, 108 patients (24.9%) of the entire cohort haddied, consisting of 86 patients (28.8%) who were classified
in the sedentary group at baseline and 22 patients (16.3%)
who were in the active group. The risk of mortality, unad-
justed for other variables, was lower (P  .005) in the
physically active group (hazard ratio  0.510, 95% CI 
0.319 to 0.816) than the sedentary group. The figure
depicts the Kaplan-Meier cumulative survival probability
for both groups throughout the follow-up period. Subse-
quently, we performed similar analyses using different cut
points to define sedentary and active groups to determine if
a threshold value in physical activity was related to mortal-
ity. Similar to the above results, when a score of 2 or greater
was used to define the active group, a significant difference
in mortality existed between sedentary and active groups (P
 .040), and when a score of 3 or greater was used to
separate the groups, a significant group difference in mor-
talilty was found as well (P .001). Using a cut point score
of 4 or above to separate groups was not possible because
very few patients (n  6) had scores that exceeded a
physical activity value of 3. Finally, when the physical
activity data was analyzed as a continuous variable with
values ranging 0 and 7, physical activity remained highly
correlated with mortality (hazard ratio 0.677, 95% CI
0.542 to 0.847, P  .001).
Proportional hazards analyses relating baseline clinical
characteristics to mortality in patients with intermittent
claudication are shown in Table III. Unadjusted values for
age (P  .001), BMI (P  .002), ABI (P  .001), history
of myocardial infarction (P  .045), baseline physical ac-
tivity (P  .001), and the WIQ stair climbing score (P 
.023) were significantly related to mortality. Furthermore,
sex (P  .065), current smoking status (P  .069),
6-minute walk distance (P  .077), and the WIQ distance
score (P  .055) approached significance. Using a forward
Fig. Cumulative survival of sedentary and physically active pa-
tients limited by intermittent claudication. The survival curves
were different between the two groups (log likelihood623.7,
2  8.71, P  .003).selection multivariate approach (Table IV), age at baseline
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(hazard ratio  1.045, 95% CI  1.019 to 1.072, P 
.001), followed by BMI (hazard ratio  0.943, 95% CI 
0.902 to 0.986, P .009), ABI (hazard ratio 0.202, 95%
CI 0.064 to 0.632, P.006), and physical activity status
(hazard ratio  0.595, 95% CI  0.370 to 0.955, P 
.031). After adjustment for these predictors, none of the
remaining variables obtained at baseline were significant
predictors of mortality (P  .05). As a final analysis, when
adjusting for all other variables, physical activity status
remained a predictor of mortality (HR 0.693, 95% CI
0.521 to 0.922, P  .012).
DISCUSSION
This investigation examined the impact of physical
activity level on all-cause mortality in PAD patients who are
functionally limited by intermittent claudication. Patients
Table III. Proportional hazards analyses relating baseline
clinical characteristics to mortality in patients with
intermittent claudication
Variables
Relative
risk
95% confidence
interval P value
Age (y) 1.052 1.027 to 1.078 .001
Body mass index
(kg)/(meter)2 0.936 0.897 to 0.977 .002
Ankle-brachial index 0.115 0.037 to 0.356 .001
Male sex 1.972 0.960 to 4.065 .065
Caucasian race 1.117 0.764 to 1.633 .569
Myocardial infarction 1.592 1.010 to 2.513 .045
Current smoking 1.418 0.973 to 2.066 .069
Diabetes 1.195 0.754 to 1.890 .449
Hypertension 0.933 0.440 to 1.976 .856
Hyperlipidemia 0.700 0.449 to 1.091 .114
COPD 1.479 0.816 to 2.681 .197
Physical activity scale
(activity score) 0.677 0.542 to 0.847 .001
6-minute walk
distance (meters) 0.998 0.995 to 1.000 .077
WIQ distance score
(%) 0.993 0.985 to 1.000 .055
WIQ speed score (%) 0.994 0.985 to 1.002 .132
WIQ stair climbing
score (%) 0.992 0.986 to 0.999 .023
WIQ, Walking impairment questionnaire; COPD, chronic obstructive pul-
monary disease.
Table IV. Multivariate Cox proportional hazards model
to predict mortality from baseline measures in patients
with intermittent claudication
Step: predictor
variables
Relative
risk
95% confidence
interval P value
Step 1: age 1.045 1.019 to 1.072 .001
Step 2: BMI 0.943 0.902 to 0.986 .009
Step 3: ABI 0.202 0.064 to 0.632 .006
Step 4: Activity group 0.595 0.370 to 0.955 .031
ABI, Ankle-brachial index; BMI, body mass index.who perform less than 1 hour of physical activity each weekthat exceeds light intensity at baseline have a lower unad-
justed risk of mortality than their sedentary counterparts,
suggesting that even minimal amounts of physical activity
performed at moderate intensity have protective effects in
PAD patients limited by intermittent claudication. Further-
more, the association between physical activity and all-
cause mortality was robust, as it remained significant even
after adjusting for other predictors of mortality such as age,
ABI, and BMI.
Our results support a recent study that found PAD
patients in the highest quartile of physical activity had lower
rates of all-cause mortality, cardiovascular disease events,
and cardiovascular mortality than those in the lowest quar-
tile.23 Since only a minority of these patients had intermit-
tent claudication, it was not clear whether the association
between physical activity and survival was present in this
subgroup. The current investigation confirms this notion
by demonstrating the beneficial effect of physical activity on
survival in PAD patients with ambulatory limitations due to
intermittent claudication. These findings also agree with
previous studies on relatively healthy middle-age and older
men. Harvard alumni who engaged in a modest amount of
weekly physical activity that exceeded 500 kcal/week had a
lower risk of mortality than those who had activity values
below this cut point.22 Similarly, men who were above the
lowest tertile for leisure-time physical activity have lower
rates of all-cause and cardiovascular mortality.20 Thus, the
results from the present investigation indicate that physical
activity level in PAD patients with intermittent claudication
has a protective effect on all-cause mortality similar to that
seen in middle-age and older men.
The intensity of physical activity necessary for patients
with intermittent claudication to perceive their physical
activity as being moderate in nature is easily attainable. The
JSC physical activity scale listed “fast walking” as an exam-
ple of an activity included in the moderate category. Since
very few PAD patients limited by intermittent claudication
typically walk fast, the majority of these patients may per-
ceive that they perform activities at a moderate level of
intensity simply by walking for any duration at a pace faster
than normal. All of the patients classified as being physically
active perceived that they did at least some of their activities
at an intensity equivalent to fast walking, whereas the
sedentary group consisted of patients who either reported
that they avoid doing physical activities altogether, or that
they never exceed a light intensity of activity such as walk-
ing at a normal pace.
Baseline ABI in this investigation was an independent
predictor of mortality, as lower ABI was associated with
greater relative risk of death. This observation supports
previous studies which found that the presence of PAD is
associated with a poor prognosis of long-term survival.1-14
Compared with subjects without PAD, the relative risk for
all-cause mortality associated with PAD ranges between 1.4
and 3.8.1,4,5,7,8,10,11,14 The 5-year survival estimate for
PAD patients and non-PAD controls is 63% and 90%,
respectively, while the 10-year survival is 46% and 77%.7This supports the current study, which found that the
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 1 Gardner et al 1215-year survival rate was approximately 75%. A subsequent
study found an even lower 10-year survival estimate of 39%
and 35% in older men and women with PAD, respec-
tively,11 whereas the 10-year survival estimate in patients
with severe symptomatic large-vessel PAD is even lower at
approximately 25%.1 Collectively, these natural history ex-
aminations have much higher mortality rates than com-
pared with randomized controlled clinical trial studies as-
sessing claudication drug therapies,33 likely because the
screening procedures and enrollment criteria in the clinical
trials are more rigorous.
The prognosis of PAD patients worsens as the severity
of PAD increases.3,6,7,10,11,14 For example, compared with
controls with ABI values greater than 0.85, patients with
ABI values between 0.40 and 0.85 have an adjusted relative
risk of mortality of 2.02, whereas patients with ABI values
below 0.40 have an adjusted relative risk of 3.35.7 This
gradient of higher relative risk of death with lower ABI is
also reported in a later study, in which patients with ABI
values between 0.31 and 0.49 have a relative risk of death of
1.17 compared with the reference group of patients with
ABI values between 0.50 to 0.91, whereas patients with
ABI values below or equal to 0.30 have a relative risk of
1.84.6 These data suggest that ABI is an important predic-
tor of the relative risk of all-causemortality in PADpatients.
The association between all-causemortality and PAD is also
evident when symptomatology is used to quantify disease.
Patients with intermittent claudication have a relative risk
of mortality that is about two-fold higher than those with-
out PAD,34-37 and patients with atypical claudication have
similar risk as those with classic symptoms of intermittent
claudication.38,39 Furthermore, a gradient exists between
the relative risk of all-cause mortality and the severity of
symptoms, as asymptomatic patients have about half the
risk as those with intermittent claudication.1 This incre-
ment in risk between asymptomatic and symptomatic pa-
tients is also evident for cardiovascular disease mortality,
and coronary heart disease mortality.1
Baseline BMI, adjusted for age, was another predictor
of mortality in this investigation, as lower BMI was associ-
ated with greater relative risk of death. This may be due to
the influential effect that cigarette smoking has on BMI, the
prevalence of PAD, and mortality. In a previous report
from our laboratory, PAD patients who were current smok-
ers had a lower BMI than former smokers who had quit
smoking for an average of 12 years prior to investigation.40
Cigarette smoking also predicts those who have PAD, as
the relative risk associated with having an ABI value below
0.90 is 2.55 in current smokers.9 Furthermore, cigarette
smoking is associated with a higher mortality rate across the
entire spectrum of relative body weight, indicating that
although smoking and BMI are interrelated, they each
exert independent effects on mortality. It is interesting that
in the present investigation BMI is more predictive of
mortality than cigarette smoking in PAD patients limited
by intermittent claudication. This suggests that additional
factors besides smoking may alter BMI, such as diet andphysical activity, thereby making it a stronger age-adjusted
predictor of mortality than smoking in PAD patients.
The physically active and sedentary groups were similar in
many baseline characteristics, except that the active patients
were younger, had higher ABI values, and had higher ambu-
latory function. Of thesemeasures, baseline age and ABIwere
also significant predictors of mortality. Baseline BMI was not
different between the active and sedentary groups, but it was a
predictor of mortality. After adjusting for age, BMI, and ABI,
physical activity status was a significant predictor of all-cause
mortality in patients with varying levels of ambulatory func-
tion. This finding suggests that physical activity is beneficial
regardless of ambulatory ability of patients limitedby intermit-
tent claudication. Thus, the recommendation of incorporat-
ing less than 1 hour ofwalking eachweek at a speed faster than
normal pace to reduce risk of death may apply equally well to
patients who have severe intermittent claudication and to
those who have milder symptoms. It is not clear whether
ambulating faster than normal represents a threshold of inten-
sity that must be attained to impact all-cause mortality, or
whether this pace is beneficial simply because it results in a
greater volumeof physical activity accomplished. If the latter is
true, it can be speculated that patients who walk at their usual
pace, but for longer durations, may reduce their risk of death
as well.
There are several limitations to this study. First, this study
used a retrospective, natural history follow-up study design.
As such, historical data such as change in physical activity
status, change in medication therapy, development of comor-
bid conditions, and the number and type of interventional
procedures performed during the follow-up period that are
typically recorded in a prospectively designed trial were not
available for the current investigation. Second, the JSC phys-
ical activity scale is a self-reported value in which patients
assessed their activity level over the preceding month. Self-
report is prone to errors, and even if accurate, the baseline
activity level over the precedingmonthmaynot reflect chronic
activity level prior to the study or the activity status during the
follow-up period. Third, the JSC physical activity scale was
developed on relatively healthymen andwomen ranging from
20 and 79 years of age to predict maximal oxygen uptake, and
was not specifically developed on patients with intermittent
claudication. Fourth, during the search in the Social Security
Death Index, we assumed that individuals were alive if they
were not listed as deceased. Some time is required for deaths
to be recorded in the registry, and it is therefore possible that
the mortality data reported in the current investigation is a
slight underestimate due to recent deaths not having been
posted at the time of our search. However, it is unlikely that
the potential underestimate in mortality was biased towards
either the sedentary or physically active groups.
In conclusion, patients limited by intermittent claudi-
cation who engage in any amount of weekly physical activ-
ity beyond light intensity at baseline have a lower mortality
rate than their sedentary counterparts who perform either
no physical activity or only light-intensity activities. The
protective effect of physical activity persists even after ad-
justing for other predictors of mortality, which include age,
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that PAD patients of varying ages, disease severity, and
body composition may reduce their heightened risk of
mortality by engaging in less than 1 hour of physical activity
each week that exceeds light intensity, such as ambulating
at speeds faster than their typical pace.
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